European Patients' Academy on Therapeutic Innovation

Project Information

EUPATI

Grant agreement ID: 115334

Project closed

Start date 1 February 2012

End date 31 January 2017

Funded under

• Specific Programme "Cooperation": Joint Technology Initiatives

Total cost € 10 951 178,00

EU contribution € 5 250 000,00

Coordinated by

VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV
Germany

Objective

"The proposed project ""European Patients' Academy on Therapeutic Innovation"" (EUPATI) contributes to IMI’s goal of raising patients’ awareness and participation in pharmaceutical R&D. This patient-led academy will provide scientifically reliable, objective, comprehensive information to patients on pharmaceutical R&D. It will increase the capacity of well-informed patients to be effective advocates and advisors, e.g. in pharmaceutical development, with regulatory authorities and in ethics committees. The Consortium, led by the European Patients' Forum, comprises a unique combination of pan-European patient organisations, academic and not-for profit organisations and 16 EFPIA member companies. It features excellence across disease areas in state-of-the art, high quality, objective education to patients about therapeutic innovation. Supported by an innovative e-platform, EUPATI's network of patients, experts, companies and communicators develops recognised blended learning courses for patients to become 'Patient Experts' in treatment development. It provides educational materials for patient organisations as well as a Wiki-type platform available to all patients in 6 areas of interest. It drives the newest thinking in content and delivery, and harnesses previously ad-hoc activities in a coherent, strategic, quality-oriented and sustainable way. It informs the lay and hard to reach patient community, raising public awareness of the development of new treatments. EUPATI makes a substantial and measurable difference to patients, laying the base for meaningful involvement and empowerment of patients in pharmaceutical innovation, safety of medicines and access to treatments. EUPATI creates synergies across its public and private partners to galvanize the most effective, transparent and credible partnership possible, nurturing the best that industry and patient organisations can offer in this field, whilst respecting core principles of quality and independence of information."

Programme(s)

• FP7-JTI - Specific Programme "Cooperation": Joint Technology Initiatives

Topic(s)

• IMI-JU-03-2010-07 - Fostering Patient Awareness On Pharmaceutical Innovation

Call for proposal

IMI-JU-03-2010
See other projects for this call

Funding Scheme

JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)

Coordinator

VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV

• EU contribution: No data
• Address: HAUSVOGTEIPLATZ 13 ; 10117 Berlin ; Germany
• Region: Berlin › Berlin › Berlin
• Activity type: Other
• Administrative Contact: Nicola Anna Bedlington (Mr)
• Principal investigator: Barbara Haake (Ms)
• Total cost: No data

Participants (32)

FORUM EUROPEEN DES PATIENTS - EUROPEAN PATIENTS' FORUM

Belgium

• EU contribution: € 1 232 402,00
• Address: Rue du Commerce ; 1000 Brussels
• Activity type: Other
• Administrative Contact: Nicola Anna Bedlington (Mr)
• Total cost: No data

DIA Europe GmbH

Switzerland

• EU contribution: € 738 610,00
• Address: Elisabethenanlage ; 4002 Basel
• Administrative Contact: Matthew May (Mr.)
• Total cost: No data

EURORDIS - RARE DISEASES EUROPE

France

• EU contribution: € 489 621,00
• Address: RUE DIDOT 96 ; 75014 Paris
• Region: Ile-de-France › Ile-de-France › Paris
• Activity type: Other
• Administrative Contact: Patrice Regnier (Mr.)
• Total cost: No data

EUROPEAN AIDS TREATMENT GROUP EV

Germany

• EU contribution: € 288 670,00
• Address: ACHENBACHSTR.5 ; 40237 Dusseldorf
• Region: Nordrhein-Westfalen › Düsseldorf › Düsseldorf, Kreisfreie Stadt
• Activity type: Other
• Administrative Contact: Koen Block (Mr.)
• Total cost: No data

Hibernia College

Ireland

• EU contribution: € 384 918,00
• Address: Clare Street ; 2 Dublin
• Administrative Contact: Antoinette Power (Ms)
• Total cost: No data

EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE

Belgium

• EU contribution: € 893 637,00
• Address: RUE DE WASHINGTON 40 ; 1050 Bruxelles / Brussel
• Region: Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest › Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest › Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
• Activity type: Other
• Administrative Contact: Fanny Senez (Ms.)
• Total cost: No data

THE UNIVERSITY OF MANCHESTER

United Kingdom

• EU contribution: € 609 438,00
• Address: OXFORD ROAD ; M13 9PL Manchester
• Region: North West (England) › Greater Manchester › Manchester
• Activity type: Higher or Secondary Education Establishments
• Administrative Contact: Katherine Boylan (Dr.)
• Total cost: No data

IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE

Ireland

• EU contribution: € 93 276,00
• Address: GROVE ROAD 1 LA TOUCHE HOUSE 1 ; 6 Dublin
• Region: Ireland › Eastern and Midland › Dublin
• Activity type: Other
• Administrative Contact: Eibhlin Mulroe (Ms)
• Total cost: No data

EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

Belgium

• EU contribution: € 56 245,00
• Address: Avenue E. Mounier 83 ; 1200 Bruxelles / Brussel
• Region: Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest › Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest › Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
• Activity type: Research Organisations
• Administrative Contact: Stephane Lejeune (Mr.)
• Total cost: No data

KOBENHAVNS UNIVERSITET

Denmark

• EU contribution: € 162 028,00
• Address: NORREGADE 10 ; 1165 Kobenhavn
• Region: Danmark › Hovedstaden › Byen København
• Activity type: Higher or Secondary Education Establishments
• Administrative Contact: Karsten Kristiansen (Mr.)
• Total cost: No data

International Society for Pharmacoeconomics and Outcomes Research Inc

United States

• EU contribution: No data
• Address: Princeton Pike ; 08648 Lawrenceville, New Jersey
• Administrative Contact: Marilyn Dix Smith (PhD)
• Total cost: No data

European Genetic Alliance Network

Belgium

• EU contribution: € 301 155,00
• Address: Avenue Louise ; 1050 Brussels
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Marijke Bouma (Ms.)
• Total cost: No data

AMGEN

Belgium

• EU contribution: No data
• Address: TELECOMLAAN 5-7 ; 1831 Diegem
• Region: Vlaams Gewest › Prov. Vlaams-Brabant › Arr. Halle-Vilvoorde
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Michael Hamann (Dr.)
• Total cost: No data

ASTRAZENECA AB

Sweden

• EU contribution: No data
• Address: Vastra Maelarhamnen ; 151 85 Sodertaelje
• Region: Östra Sverige › Stockholm › Stockholms län
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Eva Lindgren (Senior Director)
• Total cost: No data

Bayer Pharma AG

Germany

• EU contribution: No data
• Address: Muellerstrasse 178 ; 13353 Berlin
• Region: Berlin › Berlin › Berlin
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Petra Freitag (Ms)
• Total cost: No data

BOEHRINGER INGELHEIM INTERNATIONALGMBH

Germany

• EU contribution: No data
• Address: BINGER STRASSE ; 55218 Ingelheim
• Region: Rheinland-Pfalz › Rheinhessen-Pfalz › Mainz-Bingen
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Rolf Göggel (Dr.)
• Total cost: No data

CHIESI FARMACEUTICI SPA

Italy

• EU contribution: No data
• Address: Via Palermo 26/a ; 43122 Parma
• Region: Nord-Est › Emilia-Romagna › Parma
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Roberta Montacchini (Mrs.)
• Total cost: No data

ELI LILLY AND COMPANY LTD

United Kingdom

• EU contribution: No data
• Address: LILLY HOUSE BASINGVIEW ; RG21 4FA Basingstoke
• Region: South East (England) › Hampshire and Isle of Wight › North Hampshire
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Birgit Steckel-Hamann (Dr.)
• Total cost: No data

ESTEVE PHARMACEUTICALS, SA

Spain

• EU contribution: No data
• Address: PASSEIG DE LA ZONA FRANCA 109, 4A PLANTA ; 08038 Barcelona
• Region: Este › Cataluña › Barcelona
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Eduard Valenti (Dr.)
• Total cost: No data

SARD

France

• EU contribution: No data
• Address: avenue Pierre Brossolette, ; 91385 CHILLY-MAZARIN
• Administrative Contact: Laurence Mazuranok (Ir.)
• Total cost: No data

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

United Kingdom

• EU contribution: No data
• Address: Great West Road 980 ; TW89GS Brentford
• Region: London › Outer London — West and North West › Hounslow and Richmond upon Thames
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Sally Miles (-)
• Total cost: No data

MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

Germany

• EU contribution: No data
• Address: FRANKFURTER STRASSE 250 ; 64293 Darmstadt
• Region: Hessen › Darmstadt › Darmstadt, Kreisfreie Stadt
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Ninog Péresse (Ms.)
• Total cost: No data

NOVARTIS PHARMA AG

Switzerland

• EU contribution: No data
• Address: LICHTSTRASSE 35 ; 4056 Basel
• Region: Schweiz/Suisse/Svizzera › Nordwestschweiz › Basel-Stadt
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Barbara Stolz (Dr. phil. nat.)
• Total cost: No data

NOVO NORDISK A/S

Denmark

• EU contribution: No data
• Address: NOVO ALLE 1 ; 2880 Bagsvaerd
• Region: Danmark › Hovedstaden › Københavns omegn
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Jorgen Dirach (MD)
• Total cost: No data

F. HOFFMANN-LA ROCHE AG

Switzerland

• EU contribution: No data
• Address: GRENZACHERSTRASSE 124 ; 4070 Basel
• Region: Schweiz/Suisse/Svizzera › Nordwestschweiz › Basel-Stadt
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Jason Hannon (Dr.)
• Total cost: No data

JANSSEN PHARMACEUTICA NV

Belgium

• EU contribution: No data
• Address: TURNHOUTSEWEG 30 ; 2340 Beerse
• Region: Vlaams Gewest › Prov. Antwerpen › Arr. Turnhout
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Stefan Gijssels (Vice President Communication & Public Affairs EMEA)
• Total cost: No data

UCB BIOPHARMA

Belgium

• EU contribution: No data
• Address: ALLEE DE LA RECHERCHE 60 ; 1070 Bruxelles / Brussel
• Region: Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest › Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest › Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Simon DRESSE (Mr)
• Total cost: No data

ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA

Spain

• EU contribution: No data
• Address: CALLE MARIA DE MOLINA 54 ; 28006 MADRID
• Region: Comunidad de Madrid › Comunidad de Madrid › Madrid
• Activity type: Other
• Administrative Contact: AMELIA MARTÍN (Ms.)
• Total cost: No data

The Employers' Union of Innovative Pharmaceutical Companies INFARMA (Związek Pracodawców Innowacyjnych Firm Farmaceutycznych)

Poland

• EU contribution: No data
• Address: Puławska ; 02-515 Warsaw
• Administrative Contact: Paweł Wakor (Mr.)
• Total cost: No data

BRISTOL-MYERS SQUIBB COMPANY CORP

United States

• EU contribution: No data
• Address: PARK AVENUE 345 ; 10154 New York
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Katrin Rupalla (Dr.)
• Total cost: No data

PFIZER LIMITED

United Kingdom

• EU contribution: No data
• Address: RAMSGATE ROAD ; CT13 9NJ Sandwich
• Region: South East (England) › Kent › East Kent
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Olga Krylova (Dr)
• Total cost: No data

MERCK SHARP & DOHME CORP

United States

• EU contribution: No data
• Address: ONE MERCK DRIVE ; 08889 Whitehouse Station Nj
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Administrative Contact: Robert Lopata (Associate Director)
• Total cost: No data